Tower Research Capital (TRC)’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
Tower Research Capital (TRC)'s MXCT Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its MaxCyte (MXCT) stake by 52% in Q3 2026, selling an estimated $34.5K and leaving 25,794 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3562.
Tower Research Capital (TRC) first reported a position in MXCT in Q3 2021 and has held it in 21 quarters since. The position peaked at $188K in Q4 2023. 118 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.
- Tower Research Capital (TRC) held 25,794 shares of MaxCyte worth $28.9K as of Q3 2026.
- Tower Research Capital (TRC) sold 28,137 MaxCyte shares in Q3 2026, an estimated $34.5K.
- MaxCyte made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3562 holding.
- Tower Research Capital (TRC) first reported a position in MaxCyte in Q3 2021 and has held it in 21 quarters since.
- Tower Research Capital (TRC)'s MaxCyte position peaked at $188K in Q4 2023.
- 118 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.